Spear Bio launches next generation ultrasensitive immunoassay solution SPEAR UltraDetect™ to transform neurodegenerative disease research
Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR UltraDetect™ immunoassay solution. It delivers unparalleled sensitivity, specificity, precision, and scalability for…